Perrigo Announces U.S. FDA Approval for Opill® OTC Daily Oral Contraceptive

/PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that the U.S. Food and Drug Administration...

Related Keywords

United States ,Dublin ,Ireland ,American ,Frederique Welgryn ,Patrick Lockwood Taylor ,Society For Adolescent Health ,Perrigo Company ,Urologic Drugs Advisory Committee ,Nonprescription Drugs Advisory Committee ,Exchange Commission ,Company Form ,Women Health ,American College Of Obstetricians ,American Academy Of Family Physicians ,American Medical Association ,Drug Administration ,Consumer Self Care Products ,Perrigo President ,Chief Executive Officer Patrick ,American College ,Adolescent Health ,American Academy ,Perrigo Global Vice President ,Free The Pill ,Drugs Advisory Committee ,Visit Perrigo ,United States Securities ,Perrigo Company Plc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Fda Approval ,